Tokyo
Japan
11
2008-06-19
11
2010-06-22
These are the the leading inventors for applications assigned to Sankyo Co., Ltd.:
Sankyo Co., Ltd. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Antibody against tumor specific antigen as target
#2 | 2007-10-02 β Patent 7,276,344 granted on 2007-10-02Methods for using the osteoclastogenesis inhibitory factor (OCIF) protein
#3 | 2007-07-19 β Patent 7,855,056 granted on 2010-12-21Antibody against tumor specific antigen as target
#4 | 2007-04-17 β Patent 7,205,397 granted on 2007-04-17Proteins and methods for producing the proteins
#5 | 2007-03-20 β Patent 7,192,718 granted on 2007-03-20Methods for identifying a substance which specifically binds to an osteoclastogenesis inhibitory factor-binding molecule and modulates the biological activity thereof
#6 | 2006-10-24 β Patent 7,125,686 granted on 2006-10-24Proteins and methods for producing the proteins
#7 | 2006-06-15 β Patent 7,361,340 granted on 2008-04-22Antibody against tumor specific antigen as target
#8 | 2006-02-14 β Patent 6,998,242 granted on 2006-02-14Method of diagnosing metabolic bone diseases
#9 | 2005-07-19 β Patent 6,919,312 granted on 2005-07-19Bone-pathobolism treating agent
#10 | 2005-07-19 β Patent 6,919,434 granted on 2005-07-19Monoclonal antibodies that bind OCIF
#11 | 2005-02-15 β Patent 6,855,808 granted on 2005-02-15Proteins and methods for producing the proteins
404876 β